Search
Spotlight
CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: Recent Advances in Multiple Myeloma: Insights from Experts at Dana Farber Cancer Institute and Massachusetts General Hospital
CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: Recent Advances in Multiple Myeloma: Insights from Experts at Dana Farber Cancer Institute and Massachusetts General Hospital
Clinical
View More
Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer
Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer
News
Clinical Topics
Integrative Care
Global Bulletin
All News
Approval Alert
Clinical Topics
Integrative Care
Global Bulletin
All News
Approval Alert
Media
2 Minute Drill
Around the Practice
Between the Lines
Clinical Consult
Expert Interviews
Face Off
Medical World News
OncView
Podcasts
Readout 360
Year in Review
2 Minute Drill
Around the Practice
Between the Lines
Clinical Consult
Expert Interviews
Face Off
Medical World News
OncView
Podcasts
Readout 360
Year in Review
Conferences
Publications
All Journals
For Authors
Tumor Board
All Journals
For Authors
Tumor Board
CME/CE
Resources
Contemporary Concepts
Interactive Tools
Nurse Practitioners/Physician's Assistants
Partners
Sponsored
Contemporary Concepts
Interactive Tools
Nurse Practitioners/Physician's Assistants
Partners
Sponsored
Subscribe
eNewsletter
Print Subscription
eNewsletter
Print Subscription
Search
Spotlight
CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: Recent Advances in Multiple Myeloma: Insights from Experts at Dana Farber Cancer Institute and Massachusetts General Hospital
Clinical
See All >
Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer
Axicabtagene Ciloleucel for Relapsed/Refractory Large B-cell Lymphoma Following Chemoimmunotherapy
home
Articles
FDA Grants Approval to Axi-Cel for Adults With LBCL Following First-Line Chemoimmunotherapy
April 1st 2022, 10:38pm
Videos
Frederick Locke, MD, Reviews the Next Steps for Axi-Cel in LBCL
April 21st 2022
Frederick Locke, MD, Talks Unmet Needs Reduced by Axi-Cel Use in LBCL
April 16th 2022
View More